The 2-nitrate-1,3-dibuthoxypropan, a new nitric oxide donor, induces vasorelaxation in mesenteric arteries of the rat

European Journal of Pharmacology

Volumn 690, Issue 1-3, 2012, Pages 170-175

  França Silva, Maria S ^a   Luciano, Melissa N ^a   Ribeiro, Thaís P ^a   Silva, Juliane S F ^a   Santos, Alexsandro F ^a   França, Karime C ^b   Nakao, Lia S ^b   Athayde Filho, Petrônio F ^a   Braga, Valdir A ^a   Medeiros, Isac A ^a  

^a FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Nitric oxide; Organic nitrate; Vasorelaxation

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 2 NITRATE 1,3 DIBUTHOXYPROPAN; 4 AMINOPYRIDINE; CHARYBDOTOXIN; CYCLIC GMP; GLIBENCLAMIDE; GUANYLATE CYCLASE; HYDROXOCOBALAMIN; NITRIC OXIDE; NITRIC OXIDE DONOR; POTASSIUM CHANNEL; POTASSIUM CHLORIDE; TETRYLAMMONIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

ANIMALS; FREE RADICAL SCAVENGERS; GLYCEROL; GUANYLATE CYCLASE; INTRACELLULAR SPACE; MALE; MESENTERIC ARTERIES; MYOCYTES, SMOOTH MUSCLE; NITRATES; NITRIC OXIDE; NITRIC OXIDE DONORS; OXADIAZOLES; PHENYLEPHRINE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; PROPANE; QUINOXALINES; RATS; RATS, WISTAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; VASOCONSTRICTION; VASODILATION; VASODILATOR AGENTS;

EID: 84864481961     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.06.043     Document Type: Article

References (32)

1. O.A. Adaramoye, and I.A. Medeiros Endothelium-independent vasodilation induced by kolaviron, a biflavonoid complex from Garcinia kola seeds, in rat superior mesenteric arteries J. Smooth Muscle Res. 45 1 2009 39 53
2. S.L. Archer, J.M. Huang, V. Hampl, D.P. Nelson, P.J. Shultz, and K. Weir Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase P. Natl. Acad. Sci. USA 91 1994 7583 7587
3. + channel inhibitior 4-aminopyridine Eur. J. Pharmacol. 452 2002 325 337
4. R.A. Bialecki, and C. Stinson-Fisher KCa channel antagonists reduce NO donor-mediated relaxation of vascular and tracheal smooth muscle Am. J. Physiol. Lung C 268 1995 152 159
5. V.M. Bolotina, S. Najibi, J.J. Palacino, P.J. Pagano, and R.A. Cohen Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle Nature 368 1994 850 853
6. W.B. Campbell, D. Gebremedhin, P.F. Prait, and D.R. Herder Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors Circ. Res. 78 1996 415 423
7. H.M.O. Farouque, S.G. Worthley, and I.T. Meredith Effect of ATP-Sensitive Potassium Channel Inhibition on Coronary Metabolic vasodilation in Humans Arterioscler. Thromb. Vasc. 24 2004 905 910
8. C.G. Garland, and G.A. McPherson Evidence that nitric oxide does not mediate the hyperpolarization and relaxation to acetylcholine in the rat small mesenteric artery Br. J. Pharmacol. 105 1992 229 435
9. J. Garthwaite, E. Southam, C.L. Boulton, E.B. Nielsen, K. Schmidt, and B. Mayer Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1-H-[1,2,4]oxadiazo-lo[4,3-a]quinoxalin-1-one Mol. Pharmacol. 48 1995 184 188
10. P. Goyal, U. Kiran, S. Chauhan, R. Juneja, and M. Choudhary Efficacy of glyceril trinitrate inhalation in reducing pulmonary arterial hypertension in children with congenital heart disease Br. J. Anaesth. 97 2006 208 214
11. A.M. Gurney Mechanisms of drug-induced vasodilatation J. Pharm. Pharmacol. 46 1994 242 251
12. F.J. Haddy, P.M. Vanhoutte, and M. Feletou Role of potassium in regulating blood flow and blood pressure Am. J. Physiol. Reg. I Physiol. 290 2006 546 552
13. R.G. Hempelmann, J. Seebeck, A. Ziegler, and H.M. Mehdorn Effects of potassium channel inhibitors on the relaxation induced by the nitric oxide donor diethylamine nitric oxide in isolated human cerebral arteries J. Neurosurg. 93 2001 1048 1054
14. + channel blockers on beta-adrenoceptor-mediated vasorelaxation of rat mesenteric artery J. Cardiovasc. Pharmacol. 29 1997 515 519
15. W.F. Jackson Ion channels and vascular tone Hypertension 35 2000 173 178
16. H. Kojima, N. Nakatsubo, K. Kikuchi, S. Kawahara, Y. Kirino, H. Nagoshi, Y. Hirata, and T. Nagano Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins Anal. Chem. 70 1998 2446 2453
17. H. Kruszyna, J.S. Magyar, l.G. Rochelle, M.A. Russel, R.P.E. Smith, and D.E. Wilcox Spectroscopic studies of Nitric Oxide (NO) interations with Cobalamins: reaction of NO with superoxocobalamin(Iii) likely accounts for Cobalamin reversal of the biological effects of NO J. Pharmacol. Exp. Ther. 285 1998 665 671
18. + channels in photorelaxation of vascular smooth muscle Eur. J. Pharmacol. 347 1998 215 221
19. L.J. McDonald, and F. Murad Nitric oxide and cyclic GMP signaling Proc. Soc. Exp. Biol. Med. 211 1996 1 6
20. K.D. Meisheri, S.A. Khan, and J.L. Martin Vascular pharmacology of ATP-sensitive K1 channels: interactions between glyburide and K1 channel openers J. Vasc. Res. 30 1993 2 12
21. M.R. Miller, S. Grant, and R.M. Wadsworth Selective arterial dilatation by glyceryl trinitrate is not associated with nitric oxide formation in vitro J. Vasc. Res. 45 2008 375 385
22. D.I. Mistry, and C.J. Garland Nitric oxide (NO)-induced activation of large conductance Ca2-dependent K-channels (BKCa) in smooth muscle cells isolated from the rat mesenteric artery Br. J. Pharmacol. 124 1998 1131 1140
23. J. Mombouli, and P.M. Vanhoutte Endothelium-derived hyperpolarizing actor(s): updating the unknown Trends Pharmacol. Sci. 18 1997 252 256
24. K.M. Nassem The role of nitric oxide in cardiovascular diseases Mol. Aspects Med. 26 2005 33 65
25. J. Navarro-Antolin, and S. Lamas Nitrosative stress by cyclosporine A in the endothelium: studies with the NO-sensitive probe diaminofluorescein-2/ diacetate using flow cytometry Nephrol. Dial. Transplant. 16 2001 6 9
26. F. Plane, A. Hurrell, J.Y. Jeremy, and C.J. Garland Evidence that potassium channels make a major contribution to SIN-1 evoked relaxation of rat isolated mesenteric artery Br. J. Pharmacol. 119 1996 1557 1562
27. L.J. Sampson, F. Plane, and C.J. Garland Involvement of cyclic GMP and potassium channels in relaxation evoked by the nitric oxide donor, diethylamineNONOate, in the rat small isolated mesenteric artery Naunyn Schmiedeberg's Arch. Pharmacol. 364 2001 220 225
28. A. Sand, E. Andersson, and G. Fried Nitric oxide donors mediate vasodilation in human placental arteries partly through a direct effect on potassium channels Placenta 27 2006 181 190
29. Santos, A.F., 2009. Novas Perspectivas da Glicerina - Síntese de Novos Nitratos com Propriedades Farmacológicas e Melhoradores de Cetano. Dissertação (Mestrado)- - Universidade Federal da Paraíba, João Pessoa, p. 116.
30. C.A. Schmitt, and V.M. Dirsch Modulation of endothelial nitric oxide by plant-derived products Nitric Oxide: Biol. Chem. 21 2009 77 91
31. L.N. Shapoval Nitric oxide: involvement in the nervous control of cardiovascular function Neurophysiology 36 2004 466 478
32. N. Yurtseven, P. Karaca, M. Kaplan, V. Ozkul, A.K. Tuygun, and T. Aksoy Effect of glyceril trinitrate inhalation on patients with pulmonary hypertension undergoing mitral valve replacement surgery Anesthesiology 99 2003 855 858